Abstract: A system may selectively deliver interactive portions of a piece of content, based for example on a recipient user's historical tendency to use interactive portions of prior content. Multiple levels of interactivity may be defined for a given piece of content, such as an advertisement, and different users may receive different levels of interactivity based on how much they use interactive features. Some users may receive no interactive features at all, while others may receive the interactive features, and despite the fact that all of the users' devices may be perfectly capable of processing the interactive features for the user. The omission from transmission may conserve bandwidth and transmission resources.

Abstract: A medical cart for administering a magnetic agent to a patient through the ear canal is disclosed. The medical cart comprises a magnet assembly array that is configured to direct a magnetic agent into the middle ear space of the patient's ear. The magnet assembly is further configured to produce magnetic force that directs the magnetic agent to a second administration ear and opposes the force of gravity to hold the magnetic agent in the first administration ear.

Abstract: Two implant devices cooperate to form a single reinforcement device for minimizing the risk of future hip fractures in the vulnerable as being at significant risk for hip fracture. The two implant devices are sequentially inserted through the same incision and each has a respective head portion, a respectively upwardly or downwardly curved intermediate portion preferably having a generally constant rectangular cross section, and a tapered tail portion, with the head portion of the first implant device having a suitably shaped and positioned opening adapted to receive the constant cross section portion of the second device, and with an enlarged head portion of the second implant device adapted to maintain the second device at a desired orientation relative to the first device and to constrain the second device from excessive insertion relative to the first device after the two devices have been sequentially inserted through the single incision.

Abstract: Compositions of matter comprising RNA silencing molecules capable of mediating cleavage of p21 mRNA are disclosed. Methods of eradicating senescent cells or cancer cells, as well as methods of treating senescence-associated diseases or disorders, cancer, and fibrotic diseases and disorders are also disclosed.

Abstract: An actuated magnetic field is generated at a plurality of distinct frequencies that at least partially cancels an outside magnetic field at the plurality of distinct frequencies, thereby yielding a total residual magnetic field. The total residual magnetic field is coarsely detected and a plurality of coarse error signals are respectively output. The total residual magnetic field is finely detected and a plurality of fine error signals are respectively output. The actuated magnetic field is controlled respectively at the plurality of distinct frequencies at least partially based on at least one of the plurality of coarse error signals, and finely controlled respectively at the plurality of distinct frequencies at least partially based on at least one of the plurality of fine error signals.

Abstract: A method of operation for a Reed-Solomon decoder includes receiving partial input data of symbols of a Reed-Solomon codeword; updating Reed-Solomon syndromes and error location polynomial coefficients based on the partial input data; maintaining the Reed-Solomon syndromes and the error location polynomial coefficients in a memory prior to starting activation of Reed-Solomon decoding; and inputting the Reed-Solomon syndromes and the error location polynomial coefficients to a first activation of Reed-Solomon decoding including calculating an initial error evaluator polynomial as a first error evaluator polynomial, performing error detection based on the first error evaluator polynomial to determine presence and location of errors in an input Reed-Solomon codeword, and updating the error location polynomial when errors are found in the input Reed-Solomon codeword.

Abstract: A method of increasing the number of shares purchased under an employee stock purchase plan with limited or no employee capital contributions comprises permitting appreciation realized by future disposition of at least some of the shares acquired under the employee stock purchase plan to finance initial plan contributions.

Abstract: A three-part epoxy grout composition comprises a liquid epoxy blend, a liquid hardener, and a graded particulate aggregate, wherein the dry aggregate particles are pretreated with an applied adhesion promoter in an amount of 0.01 to 5% by weight. The volume of pretreated aggregate particles, when mixed with the epoxy blend and the hardener, comprises at least 70% by volume of the cured grout. Pretreatment of the aggregate by coating with adhesion promoter allows more efficient use of chemicals along with improved strength. Related methods are also disclosed.

Abstract: A system includes a radio configured to transmit and receive voice transmissions to and from air traffic control (ATC), the radio installed onboard an aircraft. The system includes a processor communicatively coupled to the radio and installed onboard the aircraft. The processor is configured to: receive an ATC voice command via the radio; transcribe the ATC voice command into an ATC command; and when the ATC command includes an aircraft identification associated with the aircraft, categorize the ATC command into components, each of the components being categorized based on a criticality level associated with said component, wherein the criticality level is or is associated with a required accuracy confidence level of transcribed speech for a given component.

Abstract: A common gate resistor bypass arrangement for a stacked arrangement of FET switches, the arrangement including a series combination of an nMOS transistor and a pMOS transistor connected across a common gate resistor. During at least a transition portion of the transition state of the stacked arrangement of FET switches, the nMOS transistor and the pMOS transistor are both in an ON state and bypass the common gate resistor. On the other hand, during at least a steady state portion of the ON steady state and the OFF steady state of the stacked arrangement of FET switches, one of the nMOS transistor and the pMOS transistor is in an OFF state and the other of the nMOS transistor and the pMOS transistor is in an ON state, thus not bypassing the common gate resistor.

Abstract: A system and method for determining magnetization and force directions for a plurality of magnetic elements that makes up a magnetic assembly on a medical cart. The magnetic assembly may be configured to generate magnetic forces that create pushing and/or pulling force on a magnetic therapeutic agent at specific locations relative to a simulated patient on the medical cart.

Abstract: The application provides devices, kits and methods for a streamlined lateral flow assay for sample preparation, optional amplification, and detection of a target nucleic acid using programmable nuclease reagents.

Abstract: The present invention provides a method for preparing a compound of Formula C, Formula D, or Formula F: wherein each R1, R2, and R3 is independently H, SF5, N(C1-C8 alkyl)(C1-C8 alkyl), C(?S)N(C1-C8 alkyl)(C1-C8 alkyl), SO2N(C1-C8 alkyl)(C1-C8 alkyl), OSO2(C1-C8 alkyl), OSO2N(C1-C8 alkyl)(C1-C8 alkyl), N(C1-C8 alkyl)SO2(C1-C8 alkyl), or C1-C8 alkyl, C1-C8 haloalkyl, C2-C8 alkenyl, C2-C8 alkynyl, C3-C10 cycloalkyl, C3-C10 halocycloalkyl, C4-C10 alkylcycloalkyl, C4-C10 cycloalkylalkyl, C6-C14 cycloalkylcycloalkyl, C5-C10 alkylcycloalkylalkyl, C3-C8 cycloalkenyl, C1-C8 alkoxy, C1-C8 haloalkoxy, C3-C8 cycloalkoxy, C3-C8 halocycloalkoxy, C4-C10 cycloalkylalkoxy, C2-C8 alkenyloxy, C2-C8 alkynyloxy, C1-C8 alkylthio, C1-C8 alkylsulfinyl, C1-C8 alkylsulfonyl, C3-C8 cycloalkylthio, C3-C8 cycloalkylsulfinyl, C3-C8 cycloalkylsulfonyl, C4-C10 cycloalkylalkylthio, C4-C10 cycloalkylalkylsulfinyl, C4-C10 cycloalkylalkylsulfonyl, C2-C8 alkenylthio, C2-C8 alkenylsulfinyl, C2-C8 alkenylsulfonyl, C2-C8 alkynylthio, C2-C8 alk

Abstract: Methods of using polypeptides to modulate transforming growth factor-? (TGF?) signaling (e.g., TGF? receptors, antibodies or antigen-binding fragments thereof that specifically bind TGF? or a TGF? receptor) are provided. Compositions comprising the antibodies or fragments thereof and methods of using the same for treatment of diseases involving TGF? activity are provided. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions comprising these antigen binding agents and fragments thereof are also disclosed. The invention also provides therapeutic methods for utilizing the TGF? signaling modulators are provided herein.

Abstract: An electrode for an electrochemical energy storage device includes an electrode active material and a crosslinked binder. The crosslinked binder includes a polyelectrolyte composed of monomer units, wherein at least a portion of the monomer units has at least one carboxyl group per unit, and a crosslinking agent, wherein the polyelectrolyte is crosslinked by the crosslinking agent. The crosslinking agent is selected from a polyphosphate and a combination of ethylenedinitrilotetraacetic acid (EDTA) with sodium ions. The electrode active material is held together by the crosslinked binder. Further provided are methods for forming the electrode, electrode slurries comprising the crosslinked binder, and electrochemical energy storage devices that employ the electrode as an anode, a cathode, or both.

Abstract: This relates to methods for measuring irregularities in a signal and corresponding devices. The devices can include a PPG sensor unit configured to detect multiple occurrences of a given event in the measured signal(s) over a sampling interval. In some instances, the device can register the occurrences of the events. In some examples, the device can include one or more motion sensors configured to detect whether the device is in a low-motion state. The device may delay initiating measurements when the device is not in a low-motion state to enhance measurement accuracy. Examples of the disclosure further include resetting the sample procedure based on one or more factors such as the number of non-qualifying measurements. In some examples, the device can be configured to perform both primary and secondary measurements, where the primary measurements can include readings using a set of operating conditions different from the secondary measurements.

Abstract: Described herein are sweat-diverting devices which can be adhered to a wearer by an adhesive. The sweat-diverting devices described here may be adhered over a portion of the face without circumscribing the head. Such sweat-diverting devices may comprise a first leg and a second leg that are joined at a base of the device to form a channel therebetween, where at least a portion of the base is more rigid than the first and second legs such that an acute angle between the first and second legs is maintained when the sweat-diverting device is applied on a wearer's forehead. In some variations, the thickness of the base is greater than the thickness of either of the legs, which may help to maintain a separation between the tips of the legs even when the sweat-diverting device is applied to a wearer's forehead.

Abstract: Provided herein are thermomer monomer, thermomer dimers, thermomer monomeric constructs, thermomer dimeric complexes, and related gene expression cassette vectors, cells, surfaces devices, compositions methods and systems, that provide a thermobioswitch suitable to control location and/or binding of cargo moiety of interest in a temperature regulated manner.

Abstract: This document presents devices, systems, and their methods of use for authenticating, evaluating, adjusting, and/or submitting a claim to a third-party obligator. The system may include a client computing device such as a cellular phone, having a downloadable application running thereon. The application running on the client computing device may be configured for generating an interface into which a characterization of treatment to be provided from a healthcare provider to a patient having a third party obligation agreement may be entered, where the obligation agreement includes terms defining coverage for treatments to be provided that will be covered by the agreement. As such, the system may be used to generate a claims submittal packet on behalf of the health care provider for reimbursement from the third party obligator for the treatments provided to the patient by the healthcare provider.

Abstract: A method of determining whether one or more forms of a nucleic acid analyte are present in a sample. The method includes dissolving an amplification reagent with a first solvent, where the amplification reagent contains oligonucleotides sufficient to amplify and detect a first region of a first form of the analyte, where the first solvent contains one or more oligonucleotides which, in combination with the oligonucleotides of the amplification reagent, are sufficient to amplify and detect a second region of a second form of the analyte, where the one or more oligonucleotides of the first solvent are insufficient to amplify and detect the first or second form of the analyte, and where the first and second regions each comprise a different nucleotide base sequence.